| Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update CR Lee, JA Luzum, K Sangkuhl, RS Gammal, MS Sabatine, CM Stein, ... Clinical pharmacology & therapeutics 112 (5), 959-967, 2022 | 227 | 2022 |
| Phase I study of 506U78 administered on a consecutive 5-day schedule in children and adults with refractory hematologic malignancies J Kurtzberg, TJ Ernst, MJ Keating, V Gandhi, JP Hodge, DF Kisor, ... Journal of Clinical Oncology 23 (15), 3396-3403, 2005 | 199 | 2005 |
| Importance of the organ-independent elimination of cisatracurium DF Kisor, VD Schmith, WA Wargin, CA Lien, E Ornstein, DR Cook Anesthesia & Analgesia 83 (5), 1065-1071, 1996 | 165 | 1996 |
| Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation AM De Wolf, JA Freeman, VL Scott, W Tullock, DA Smith, DF Kisor, ... British journal of anaesthesia 76 (5), 624-628, 1996 | 150 | 1996 |
| Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. V Gandhi, W Plunkett, CO Rodriguez Jr, BJ Nowak, M Du, M Ayres, ... Journal of clinical oncology 16 (11), 3607-3615, 1998 | 132 | 1998 |
| Clinical pharmacokinetics of cisatracurium besilate DF Kisor, VD Schmith Clinical pharmacokinetics 36 (1), 27-40, 1999 | 114 | 1999 |
| Pharmacokinetics of Nelarabine and 9-Beta-d-Arabinofuranosyl Guanine in Pediatric and Adult Patients During a Phase I Study of Nelarabine for the Treatment of … DF Kisor, W Plunkett, J Kurtzberg, B Mitchell, JP Hodge, T Ernst, ... Journal of clinical oncology 18 (5), 995-995, 2000 | 98 | 2000 |
| Educational strategies to enable expansion of pharmacogenomics-based care KW Weitzel, CL Aquilante, S Johnson, DF Kisor, PE Empey American Journal of Health-System Pharmacy 73 (23), 1986-1998, 2016 | 96 | 2016 |
| Pharmacokinetics of cisatracurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia CA Lien, VD Schmith, MR Belmont, A Abalos, DF Kisor, JJ Savarese The Journal of the American Society of Anesthesiologists 84 (2), 300-308., 1996 | 75 | 1996 |
| Pharmacokinetics of RheothRx injection in healthy male volunteers RC Jewell, SP Khor, DF Kisor, KAK LaCroix, WA Wargin Journal of pharmaceutical sciences 86 (7), 808-812, 1997 | 70 | 1997 |
| Pharmacogenomics competencies in pharmacy practice: a blueprint for change MW Roederer, GM Kuo, DF Kisor, RF Frye, JM Hoffman, J Jenkins, ... Journal of the American Pharmacists Association 57 (1), 120-125, 2017 | 67 | 2017 |
| Drug–gene interactions: inherent variability in drug maintenance dose requirements P Westervelt, K Cho, DR Bright, DF Kisor Pharmacy and Therapeutics 39 (9), 630, 2014 | 48 | 2014 |
| Ambient temperature effects on 3, 4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys ML Banks, JE Sprague, DF Kisor, PW Czoty, DE Nichols, MA Nader Drug Metabolism and Disposition 35 (10), 1840-1845, 2007 | 46 | 2007 |
| Pharmacogenetics and pathophysiology of CACNA1S mutations in malignant hyperthermia TA Beam, EF Loudermilk, DF Kisor Physiological Genomics, 2017 | 45 | 2017 |
| Nelarabine in the treatment of refractory T-cell malignancies AM Roecker, A Stockert, DF Kisor Clinical Medicine Insights: Oncology 4, CMO. S4364, 2010 | 41 | 2010 |
| A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics DM Calinski, DF Kisor, JE Sprague Psychopharmacology 236, 881-890, 2019 | 40 | 2019 |
| Population pharmacokinetics of gentamicin: use of the nonparametric expectation maximisation (NPEM) algorithm DF Kisor, SM Watling, BJ Zarowitz, RW Jelliffe Clinical pharmacokinetics 23, 62-68, 1992 | 37 | 1992 |
| Impact of common clandestine structural modifications on synthetic cathinone “bath salt” pharmacokinetics GG Grecco, DF Kisor, JS Magura, JE Sprague Toxicology and Applied Pharmacology 328, 18-24, 2017 | 32 | 2017 |
| Pharmacists leading the way to precision medicine: updates to the core pharmacist competencies in genomics RS Gammal, YM Lee, NJ Petry, O Iwuchukwu, JM Hoffman, DF Kisor, ... American Journal of Pharmaceutical Education 86 (4), 8634, 2022 | 29 | 2022 |
| Nelarabine: a nucleoside analog with efficacy in T-cell and other leukemias DF Kisor Annals of Pharmacotherapy 39 (6), 1056-1063, 2005 | 28 | 2005 |
